We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
Risk of developing progressive multifocal leukoencephalopathy (PML) associated with natalizumab is increased in patients who have had previous immunosuppressant therapy.
The CMA is consulting on proposed commitments from Essential Pharma to keep a key bipolar drug on the market, and ensure it is affordable to the NHS.
A pioneering scheme to provide new antibiotics to NHS patients by offering to pay pharmaceutical companies upfront for their work will start this week.
A pharmaceutical company supported by Innovate UK is leading the world in the search for vital new antibiotics to treat resistant bacteria.
Acadia’s completed acquisition of Priory faces being referred for an in-depth investigation by the CMA.
The IPO’s trial on preliminary indicators in trade mark oppositions.
The proposed merger of 2 DNA sequencing system firms, Illumina and PacBio, raises competition concerns, an in-depth CMA review has provisionally found.
While an urgent EU-wide review of new information on liver safety is under way, promptly review patients on treatment. Only initiate daclizumab in restricted groups of patients with limited treatment options and keep all patients under close liver function monitoring.
Prima Uno deal is the first for Project Controls under new procurement route.
Perform a quantitative serum anti-JCV antibody test—including index value—to support risk stratification for progressive multifocal leukoencephalopathy. For high-risk patients, consider more frequent MRI screening.
Letters were sent to healthcare professionals about Zinbryta▼ (daclizumab beta), Lynparza 50 mg capsules, and radium-223-dichloride (Xofigo▼).
Illumina has abandoned its anticipated $1.2 billion takeover of PacBio after an in-depth CMA merger probe highlighted serious competition concerns.
The Competition and Markets Authority will require Breedon Aggregates Limited to sell an asphalt plant in the Aberdeen area and a ready-mix concrete plant in the Peterhead area. It will also face a price control for asphalt produced in the...
The CMA investigated the supply and acquisition of energy in Great Britain and has published its final orders and undertakings.
From 14 August, we will test wider rejection criteria for applications to create new freehold or leasehold titles (first registrations).
The CMA investigated the completed acquisition by Acadia Healthcare Company, Inc. of Priory Group No. 1 Limited.
Employment Tribunal decision.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).